Lorcaserin Use in the Management of Morbid Obesity in a Pre‐Liver Transplant Patient
- Read more about Lorcaserin Use in the Management of Morbid Obesity in a Pre‐Liver Transplant Patient
Julio A. Gutierrez, Carmen Landaverde, Jennifer T. Wells, Fred Poordad – 17 March 2016 – Management of obesity and decompensated cirrhosis in those requiring liver transplantation (LT) is a challenging dilemma. Because of concerns for perioperative complications, many centers avoid transplant in those with a body mass index (BMI) greater than 40 kg/m2. Bariatric surgery is associated with increased risk attributable to complications of portal hypertension, including variceal rupture. Therefore, weight loss and LT options are limited.